Cases & Deals

  • Home
  • Practices
  • Board of Trustees of Univ. of Illinois settles patent infringement dispute involving generic version of Prezista®

Share

Board of Trustees of Univ. of Illinois settles patent infringement dispute involving generic version of Prezista®

April 2014

Client(s) Board of Trustees of the University of Illinois, The

Jones Day represented the Board of Trustees of the University of Illinois in consolidated patent infringement actions against Mylan Pharmaceuticals Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., and Teva Pharmaceuticals USA, Inc., relating to the defendants' submission of Abbreviated New Drug Applications to the FDA seeking approval of generic versions of Prezista® (darunavir), a market-leading protease inhibitor. We worked closely with the United States, which co-owns the patent-in-suit, and with our licensee Janssen Products, L.P., which markets Prezista® (darunavir). The matters settled shortly before trial pursuant to an agreement whereby the USA and the University granted a license to defendants in exchange for a royalty based on sales of their generic products during the term of the licensed patents.

Janssen Products, L.P., et al. v. Lupin Limited, et al., Case No. 2-10-cv-05954 (D.N.J.) (Judge Walls)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.